Trial Outcomes & Findings for Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community (NCT NCT06289192)
NCT ID: NCT06289192
Last Updated: 2025-09-10
Results Overview
Acceptability and Feasibility will be assessed by the number of participants who complete intervention and surveys
COMPLETED
PHASE4
5 participants
3 months
2025-09-10
Participant Flow
Participant milestones
| Measure |
Smoking Cessation Intervention
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
|
|---|---|
|
Overall Study
STARTED
|
5
|
|
Overall Study
COMPLETED
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
Baseline characteristics by cohort
| Measure |
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
|
|---|---|
|
Age, Customized
<50 years
|
0 Participants
n=5 Participants
|
|
Age, Customized
>=50 years
|
5 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Current tobacco use
|
5 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 3 monthsAcceptability and Feasibility will be assessed by the number of participants who complete intervention and surveys
Outcome measures
| Measure |
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.
Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges.
Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.
Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
|
|---|---|
|
Acceptability and Feasibility as Assessed by the Number of Participants Who Complete Intervention and Surveys
Intervention completed
|
5 Participants
|
|
Acceptability and Feasibility as Assessed by the Number of Participants Who Complete Intervention and Surveys
All surveys completed
|
5 Participants
|
PRIMARY outcome
Timeframe: Baseline, 1 month, 3 monthsAcceptability and Feasibility will be assessed by barriers to screening
Outcome measures
| Measure |
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.
Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges.
Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.
Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
|
|---|---|
|
Acceptability and Feasibility as Assessed by Barriers to Screening
Barriers to LDCT Screening, Baseline
|
25.2 barriers
Standard Deviation 8.6
|
|
Acceptability and Feasibility as Assessed by Barriers to Screening
Barriers to LDCT Screening, 1 Month
|
28.6 barriers
Standard Deviation 14.4
|
|
Acceptability and Feasibility as Assessed by Barriers to Screening
Barriers to LDCT Screening, 3 Months
|
31.8 barriers
Standard Deviation 14.7
|
SECONDARY outcome
Timeframe: 3 monthsNumber of participants that start using NRTs during the study period
Outcome measures
| Measure |
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.
Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges.
Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.
Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
|
|---|---|
|
Number of Participants That Uptake Nicotine Replacement Therapy
|
4 Participants
|
SECONDARY outcome
Timeframe: 3 monthsTotal number of interactions with CHW across all participants
Outcome measures
| Measure |
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.
Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges.
Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.
Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
|
|---|---|
|
Participant Engagement With Community Health Worker (CHW) as Assessed by Number of CHW Interactions
|
60 CHW interactions
|
Adverse Events
Smoking Cessation Intervention
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place